Health product recall

Teva-Cotridin (2020-06-01)

Starting date:
June 1, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73273

Last updated: 2020-06-09

Summary

  • Product: Teva-Cotridin Syrup

Reason

Affected lots contain Codeine Phosphate levels outside of the labelled claim.

Depth of distribution

Wholesalers, Retailers

Affected products

Teva-Cotridin Syrup

DIN, NPN, DIN-HIM

DIN 02169126

Dosage form

Syrup

Strength

  • Codeine phosphate 10 mg/5 mL
  • Pseudoephedrine hydrochloride 30 mg/5 mL
  • Triprolidine hydrochloride 2 mg/5 mL

Lot or serial number

680026, 680046

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: